Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $15.8400 (-0.44%) ($15.6700 - $15.8400) on Mon. Aug. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.64% (three month average) | RSI | 62 | Latest Price | $15.8400(-0.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWC(57%) IWO(54%) IWM(53%) IBUY(51%) | Factors Impacting EDIT price | EDIT will decline at least -3.32% in a week (0% probabilities). VIXM(-19%) UUP(-15%) TBT(-10%) VXX(-9%) EDOC(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.32% (StdDev 6.64%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $16.25(-2.52%) | 10 Day Moving Average | $16.46(-3.77%) | 20 Day Moving Average | $15.7(0.89%) | To recent high | -9.1% | To recent low | 59.4% | Market Cap | $984m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |